Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain.
- DOI
- 10.1080/13696998.2021.1941065
- Published
- 2021 Jan-Dec
- Container
- Journal of medical economics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13696998.2021.1941065,
title = {Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain.},
author = {González-Barcala FJ and Muñoz-Gall X and Mariscal E and García A and Yang S and van de Wetering G and Izquierdo-Alonso JL},
year = {2021},
journal = {Journal of medical economics},
doi = {10.1080/13696998.2021.1941065},
url = {https://doi.org/10.1080/13696998.2021.1941065}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain. AU - González-Barcala FJ AU - Muñoz-Gall X AU - Mariscal E AU - García A AU - Yang S AU - van de Wetering G AU - Izquierdo-Alonso JL PY - 2021 JO - Journal of medical economics DO - 10.1080/13696998.2021.1941065 UR - https://doi.org/10.1080/13696998.2021.1941065 ER -
APA
FJ, G., X, M., E, M., A, G., S, Y., G, V. D. W., & JL, I. (2021). Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain.. Journal of medical economics. https://doi.org/10.1080/13696998.2021.1941065
Source records
- pubmed · retrieved 2026-09-26T15:44:58.192Z